Production of Inflammatory Molecules in Peripheral Blood Mononuclear Cells from Severely Glucose-6-Phosphate Dehydrogenase-Deficient Subjects
Authors:
- Rosa Rita BonatestaRBRosa Rita Bonatesta
- Bruno FrongiaBFBruno Frongia
- Sabrina UdaSUSabrina Uda
- Sebastiano BanniSBSebastiano Banni
- Maria Paola MelisMMMaria Paola Melis
- Maria ColluMCMaria Collu
- Clelia MadedduCMClelia Madeddu
- Roberto SerpeRSRoberto Serpe
- Silvana PudduSPSilvana Puddu
- Giovanna PorcuGPGiovanna Porcu
- Sandra DessìSDSandra Dessì
- 15 March 2007
- journal article
- Published by S. Karger AG in Journal of Vascular Research
- Vol. 44 (4) , 253-263
Abstract
Objective: We have previously demonstrated that Mediterranean glucose-6-phosphate dehydrogenase (G6PD)-deficient peripheral blood mononuclear cells (PBMC) respond to mitogenic stimuli with a reduced cholesterol synthesis and growth. In the present study, we have investigated the release of inflammatory molecules by PBMC following a mitogenic stimulus, as well as the transformation to foam cells of monocyte-derived macrophages from severely G6PD-deficient and normal subjects. Methods and Results: PBMC from G6PD-deficient subjects produced interleukin (IL)-1β and IL-6 to a lower extent compared with normal subjects. 5-Hydroxyeicosatetraenoic acid, a primary product of 5-lipoxygenase, was slightly decreased. Tumour necrosis factor-α and IL-1β secretion was significantly reduced in monocyte-derived macrophages. No difference was found in IL-10 secretion, whereas transforming growth factor-β was invariably found to be significantly higher in G6PD-deficient cells. In cells incubated with acetylated low-density lipoprotein, cholesterol esterification and its storage in lipid droplets were lower than in normal G6PD cells. Conclusions: We conclude that by reducing the secretion of inflammatory molecules by PBMC and increasing the secretion of transforming growth factor-β and the capability of monocyte-derived macrophages to accumulate lipid droplets and convert into foam cells, G6PD deficiency may confer a partial protection against atherosclerosis leading to the reduced risk of cardiovascular diseases reported in G6PD-deficient subjects.Keywords
This publication has 33 references indexed in Scilit:
- G6PD is indispensable for erythropoiesis after the embryonic-adult hemoglobin switchBlood, 2004
- β-Thalassemia Is a Modifying Factor of the Clinical Expression of Familial HypercholesterolemiaSeminars in Vascular Medicine, 2004
- Comprehensive Analysis of Genetic Polymorphisms in the Interleukin-10 Promoter: Implications for Immune Regulation in Specific Ethnic PopulationsGenetic Testing, 2004
- Inflammation in atherosclerosisNature, 2002
- Attenuated Monocyte Il-10 Production in Glucose-6-Phosphate Dehydrogenase-Deficient Trauma PatientsShock, 2002
- Cell growth and cholesterol metabolism in human glucose‐ 6‐phosphate dehydrogenase deficient lymphomononuclear cellsCell Proliferation, 2002
- Characterization of conjugated linoleic acid and its metabolites by RP-HPLC with diode array detectorEuropean Journal of Lipid Science and Technology, 2001
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- The molecular basis of glucose-6-phosphate dehydrogenase deficiencyTrends in Genetics, 1992
- Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the mediterranean variant of glucose-6-phosphate dehydrogenaseInternational Journal of Cancer, 1987